May 2, 2019 8:30am-2:30pm
In partnership with EY and Scientific American, Bioethics International will hosts its 10th annual Forum on what it means to be a trustworthy, patient-centered & ethical pharma and healthcare innovation company.
Location: New York, NY
June 9, 2022 9am-4:15pm
This year’s bioethics roundtable, our 12th!, is hosted by Deloitte and will focus on equity and social responsibility in the bio-pharmaceutical sector and debut our new Good Pharma Scorecard (GPS) rankings on diversity and fair inclusion in research.
When: June 9, 2022 – 9am-4:15pm ET
Where: Deloitte’s NYC Offices
Register Here: Pharma Executive Roundtable RSVP Form
September 21, 2020 1:00PM-2:15PM EDT
ISPOR and the Innovation and Value Initiative (IVI) are collaborating—with help from an expert advisory committee—to define a series of dialogues that highlight key challenges confronting HEOR methodologists, patients, clinicians, and policy-makers during the COVID-19 pandemic. The webinar series will explore multiple viewpoints and focus on potential pathways for solutions in international and U.S.-focused health technology assessment and value assessment (VA/HTA).
June 23, 2019 — June 27, 2019
Panelists will explore the pros and cons of the pathway from the patient perspective and learn about how regulators and sponsors may help facilitate the development of critically needed treatments. This discussion will introduce a streamlined approach to early-stage development of therapies to address severely debilitating or life-threatening diseases and consider the potential value of a global regulatory approach.
Location: San Diego, CA
June 5, 2019 — June 7, 2019
Dr. Jennifer E. Miller answers “Whose Data Is It” question.
This 75-minute session will look at the ethical considerations, legal aspects, coaching perspectives and athletic viewpoints related to ownership of sports biometric data. This session will be moderated by Jeremy Abbate from Scientific American.
Location: Columbus, Ohio
September 16, 2019 — May 16, 2019
In June 2019, Cambridge University Press published Transparency in Health and Health Care in the United States, a volume, edited by Holly Fernandez Lynch, I. Glenn Cohen, Carmel Shachar, and Barbara J. Evans, with a chapter on clinical trial transparency and data sharing by Jennifer Miller (Founder of Bioethics International and an Assistant Professor at Yale) stemming from Harvard’s Petrie-Flom Center’s 2017 conference, on this health policy buzzword, recognizing its true limitations, so that transparency can be utilized as a solution to pressing health policy issues. Jennifer E. Miller will speak on a panel with Glenn Cohen and Holly Fernandez Lynch
May 2, 2019 8:30am-2:30pm
In partnership with EY and Scientific American, Bioethics International will hosts its 10th annual Forum on what it means to be a trustworthy, patient-centered & ethical pharma and healthcare innovation company.
Location: New York, NY
